
|Videos|December 13, 2020
Analysis of investigational ophthalmic solution for treating presbyopia-related symptoms
Author(s)Alex Delaney-Gesing , David Hutton
Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.
Advertisement
Michael R. Robinson, MD, vice president, Global Therapeutic Area Head, Ophthalmology at Allergan, an AbbVie company, discusses the results from a presentation titled, "Two Phase b Study Results for the Development of a Proprietary Formulation for the Treatment of Presbyopia," presented during the virtual AAO 2020 meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
Pterygium width may help predict corneal optical disturbance
5






















